The number of COVID-19 studies is quickly increasing day by day. However, several studies have been suspended. Among these, an update on Tocilizumab comes from Italian researchers that had started a randomised controlled trial.


The number of COVID-19 studies is quickly increasing day by day. However, several studies have been suspended. Among these, an update on Tocilizumab comes from Italian researchers that had started a randomised controlled trial.

The article “Evaluation of the effectiveness and safety of Deferiprone compared to Deferasirox in pediatric patients with hemoglobinopathies (DEEP-2)” was recently published on The Lancet Haematology Journal.

The EMA’s human medicines committee (CHMP) has recommended granting a conditional marketing authorisation to Veklury (Remdesivir) for the treatment of COVID-19 in adults and adolescents from 12 years of age with pneumonia who require supplemental oxygen.

Fondazione Gianni Benzi collaborated in the article “Ethical, Legal and Regulatory Issues of Paediatric Translational Research. Call for an Adequate Model of Governance” that was published on the European Journal of Health Law.

Aliyu Mande, health information officer at Ahmadu Bello Teaching Hospital, Zaria (Nigeria), replied to some questions about the COVID-19 management in his country with a focus on Sickle Cell Disease (SCD) patients. The interview is in the context of the FGB activities within the ARISE project.

Fondazione Gianni Benzi published a new article on the special issue “Innovation and Healthcare” of the European Journal of Health Law, focused on Artificial Intelligence (AI), Machine Learning (ML) and Data Science, key areas of interest at the foundation, that are rapidly developing in healthcare, as well as on their translation into laboratory medicine and clinical practise.

It is now online the COVID-19 page on our website! This page intends to provide with an overview of the clinical trials and studies currently conducted worldwide for COVID-19. Fondazione Gianni Benzi will provide detailed information on the studies including phase, study design and results when available

The second session of the webinar, to be held on Thursday 28th May, 2020 at 04:00 PM (UK time), will be the occasion to discuss with some relevant experts in the field to better understand the impact of COVID-19 on the SCD population, drawing conclusions from both the US and Lebanon. The emotional impact of the disease will be addressed as well.

Annalisa Landi, researcher of Fondazione Gianni Benzi, collaborated on the manuscript “Different strategies to execute multi-database studies for medicines surveillance in real world setting: a reflection on the European model” that describes the relevant role of the of post-marketing safety studies, in particular of the multi-databases studies, in providing more useful information on medicines safety.

In Africa governments and health authorities across the continent are striving to limit widespread infections. The World Health Organisation Regional Office for Africa (WHO AFRO) is working closely with its 47 Member States, as well as partners, in order to implement several emergency preparedness and response interventions.
Recent posts in News